Categories
CDE Diabetes

Practice Exam: Clinical Tools & Resources (Appendices)

The Appendices of the 2018 Guidelines are not merely supplementary material; they are the “engine room” of clinical practice. They provide the practical tools, algorithms, and reference charts necessary to translate evidence into daily patient care—from safe insulin titration and sick day management to comprehensive foot exams and driving safety assessments.

This practice exam tests your proficiency in utilizing these essential tools to ensure patient safety, accurate classification, and effective self-management support.

Key Concepts Covered in This Exam:

  • Sick Day Management: Mastering the “SADMANS” protocol—knowing which medications (like sulfonylureas, ACE inhibitors, diuretics, metformin, and SGLT2 inhibitors) to pause during acute illness to prevent kidney injury and adverse effects.
  • Insulin Pharmacokinetics: Memorizing the onset, peak, and duration of various insulin types (e.g., rapid-acting analogues vs. NPH vs. long-acting basal insulins) to optimize timing and prevent hypoglycemia.
  • Titration Protocols: Applying the specific algorithms for starting and adjusting basal insulin, such as the rule to increase basal insulin by 1 unit daily until the fasting glucose target is reached.
  • Neuropathy Screening: Understanding the correct technique for using the 10g Semmes-Weinstein monofilament and the 128 Hz tuning fork to detect loss of protective sensation and assess ulcer risk.
  • Etiologic Classification: Differentiating between Type 1, Type 2, and “Other specific types” of diabetes, including those induced by drugs (e.g., glucocorticoids, atypical antipsychotics) or genetic defects (e.g., MODY).

1. Case: A patient on basal insulin experiences 2 episodes of hypoglycemia (BG <4.0 mmol/L) in one week with no nocturnal episodes. What is the appropriate action according to titration guidelines?

2. Case: A patient is prescribed Humalog Mix 25 premixed insulin. When should this insulin be administered relative to meals?

3. Case: A patient on insulin with type 2 diabetes is asking about safe driving practices. According to the Driving Assessment Form, how often should blood glucose be monitored while driving?

4. According to the Step Count Prescription, what is the goal for step count increase above baseline within 1 year?

5. Case: A diabetes educator is reviewing the comprehensive care of an elderly patient with multiple comorbidities. According to the Patient Care Flow Sheet, which combination of monitoring parameters addresses cardiovascular risk assessment?

6. What is the target fasting blood glucose level recommended when titrating basal insulin according to the insulin initiation guidelines?

7. Case: A patient with type 2 diabetes is using sulfonylureas and has an occupation requiring strict avoidance of hypoglycemia. According to the SMBG tool, how frequently should they monitor blood glucose?

8. Case: A 58-year-old patient with type 2 diabetes develops gastroenteritis with vomiting and diarrhea. She takes metformin, gliclazide, and ramipril. Which medication management is most appropriate?

9. Case: A patient with neuropathy testing scores 3.5 out of 8 on the monofilament screening. What does this score indicate about their 4-year risk?

10. According to the Diabetes Charter, which of the following is a RIGHT of Canadians living with diabetes?

11. Case: A patient with diabetes asks about foot care. According to the Foot Care Checklist, which practice should be AVOIDED?

12. Case: A diabetes team is evaluating their approach to multiple daily injection (MDI) therapy. According to insulin initiation guidelines, when calculating total daily dose for basal-bolus therapy, how should the total insulin dose be distributed?

13. Case: A patient with type 2 diabetes taking sitagliptin (a DPP-4 inhibitor) becomes acutely ill with dehydration. According to sick-day management principles, what is the rationale for continuing this medication?

14. Case: A patient with type 2 diabetes on basal insulin has a fasting blood glucose of 8.5 mmol/L for three consecutive days. According to the titration guidelines, what adjustment should be made?

15. Case: A diabetes educator is developing patient education materials about insulin therapy. A patient on insulin glargine U-300 (Toujeo®) notices that their previous insulin glargine U-100 (Lantus®) lasted about 24 hours and asks about the new formulation. What is the most accurate explanation?

16. According to the Sick-Day Medication List, which mnemonic helps remember medications to hold during acute illness?

17. According to the SMBG Recommendation Tool, how frequently should a person using basal-bolus insulin injection therapy (≥4 times per day) monitor their blood glucose?

18. According to the vibration tuning fork neuropathy screening (“On-Off” method), how many times should the procedure be performed on each foot?

19. According to the monofilament testing guidelines, at how many sites on each foot should the 10g Semmes-Weinstein monofilament be applied?

20. According to the Patient Care Flow Sheet, what is the recommended blood pressure target?

21. Case: A healthcare team is implementing a comprehensive diabetes management program. According to the Diabetes Charter, which stakeholder responsibility is correctly matched?

22. What is the onset of action for rapid-acting insulin analogues such as insulin aspart (NovoRapid®)?

23. Case: A diabetes educator is developing a foot care education program. According to the Foot Care Checklist, why should patients with diabetes NOT soak their feet?

24. A patient presents with a diabetic foot ulcer. According to the foot ulcer management essentials, which statement about cultures is correct?

25. Case: A patient with diabetes is sick with a respiratory infection and has been advised to hold certain medications. Which medication class should NOT be stopped during illness?

26. What is the duration of action for insulin degludec (Tresiba®)?

27. Case: A patient on NPH insulin (Humulin N) asks when they should expect to see the peak effect of their insulin. What is the correct answer?

28. Case: A patient is being intensified from basal insulin to basal-bolus therapy. What is the recommended starting dose for prandial insulin at the main meal?

29. Case: A 45-year-old patient with type 2 diabetes, treated only with healthy behaviour interventions and meeting glycemic targets, asks about SMBG frequency. What is the most appropriate recommendation?

30. Case: A patient with a plantar-surface diabetic foot ulcer is being managed. What is the most important pressure-related intervention?

31. What is the suggested starting dose for basal insulin when initiating insulin therapy in type 2 diabetes?

32. Case: A commercial truck driver with type 2 diabetes on insulin asks about maintaining their commercial license. According to the Driving Assessment Form, what additional requirement applies to commercial drivers compared to private drivers regarding hypoglycemia history?

33. According to the etiologic classification, which of the following is classified as a genetic defect of beta-cell function (MODY)?

34. Case: A patient currently averaging 4,500 steps per day comes in for their first clinic visit to start a step count prescription. What step count goal should be recommended?

35. Case: A patient on premixed insulin 30/70 (Humulin 30/70) twice daily is not achieving target fasting BG (currently 8.2 mmol/L). According to titration guidelines, which dose should be adjusted?

36. Case: A diabetes educator is performing a foot exam using the 10g monofilament. The patient correctly identifies 4 out of 8 stimuli. How should this result be interpreted?